Oscotec Inc
Company Profile
Business description
Oscotec Inc is a research-oriented drug development and biotechnology company have focused on developing synthetic new drugs for diseases such as arthritis and anticancers since its inception. The firm has established a differentiated business model by commercializing various research products and accumulating knowledge obtained during the drug development process into functional materials, related products, and bone graft materials. Based on its business model, its core businesses are: 1) New drug development (synthetic new drugs), 2) Functional materials and related products, and 3) Dental bone graft materials.
Contact
700, Daewangpangyyo-ro
A-901, Bundang-gu
Gyeonggi-do
Seongnam-si
KORT: +82 316287666
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2026
Employees
53
Stocks News & Analysis
stocks
SK Hynix Earnings: We raise fair value estimate on strong AI memory demand
stocks
Meta shares are down 12% since earnings. Is the stock a buy?
stocks
SpaceX earnings: We raise our fair value estimate on scaling data centres, but is the stock a buy?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,012.60 | 41.20 | 0.46% |
| CAC 40 | 7,970.00 | 83.04 | 1.05% |
| DAX 40 | 26,039.68 | 335.66 | 1.31% |
| Dow JONES (US) | 52,342.62 | 132.48 | -0.25% |
| FTSE 100 | 10,722.07 | 27.57 | 0.26% |
| HKSE | 22,958.65 | 136.18 | -0.59% |
| NASDAQ | 26,184.72 | 365.13 | -1.38% |
| Nikkei 225 | 64,659.47 | 705.28 | 1.10% |
| NZX 50 Index | 13,710.17 | 18.84 | 0.14% |
| S&P 500 | 7,720.22 | 23.76 | -0.31% |
| S&P/ASX 200 | 8,891.80 | 44.50 | 0.50% |
| SSE Composite Index | 3,651.43 | 30.04 | -0.82% |